Cardiac effects of L-thyroxine administration in borderline hypothyroidism

To investigate the clinical relevance of l-thyroxine (l-T(4)) substitution therapy in borderline hypothyroidism.

To assess whether and to what extent administration of l-T(4) is able to modify systolic and diastolic function in patients with subclinical hypothyroidism and in subjects with autoimmune thyroiditis and normal serum TSH.

We studied 26 patients with classical Hashimoto's thyroiditis [18 with increased serum TSH (>3 mU/ml - Group A), and 8 with normal serum TSH (<3 mU/ml) - Group B]; a third group (C) included 13 healthy controls. All subjects underwent Pulsed Wave Tissue Doppler Imaging (PWTDI) to accurately quantify the global and regional left ventricular function.

In both groups A and B we confirmed a significant impairment of systolic ejection (p<0.001 and p<0.05, respectively), a delay in diastolic relaxation (p<0.001 and p<0.05, respectively) and a decrease in the compliance to the ventricular filling (p<0.05). Administration of 50 microg/day of l-T(4) produced a progressive reduction of serum TSH (within the normal range) and normalization of all PWTDI parameters, which began after 6 months and finished after 12 months.

Our data confirm previous evidence that subclinical hypothyroidism is associated with a cardiac dysfunction, even when this is very mild (i.e. with serum TSH still comprised in the normal range), and show that these abnormalities are reversible with l-T(4) replacement therapy.